PolyPeptide Group AG (SWX:PPGN)
Switzerland
· Delayed Price · Currency is CHF 17.12
-0.26 (-1.50%)
Apr 24, 2025, 4:21 PM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 573.48 million as of April 24, 2025. Its market cap has decreased by -39.18% in one year.
Market Cap
573.48M
Enterprise Value
607.83M
Revenue
315.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.12
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 573.48M, a decrease of -77.86%. That is a compound annual growth rate of -31.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 573.48M | -38.78% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 204.44B |
| Novartis AG | 172.07B |
| Lonza Group AG | 38.79B |
| Alcon | 37.42B |
| Galderma Group AG | 18.40B |
| Straumann Holding AG | 15.49B |
| Sonova Holding AG | 14.12B |
| Sandoz Group AG | 13.94B |